01
FoundationEvidence base
Research continues to define the access, trust and workflow assumptions that shape the product.
ANTHOVIANCurrent product pipeline
A focused route from proof to network.
Anthovian’s roadmap prioritises a narrow product, credible partner adoption and measured expansion. Each stage is intended to reduce risk before more capital or complexity is introduced.
Investment logicProve the workflow. Earn the network.
Public milestones show where value should be created. Product mechanics, partner methods and detailed operating plans remain private.
Current focusPrivate product build
Next gateControlled partner pilot
Expansion logicProof before breadth
DisclosureStages, not dates
02
CurrentPrivate product build
A focused product experience is being developed around the core prescription-to-fulfilment handoff.
03
NextControlled partner pilot
Prepare a narrow Thailand-first pilot with selected clinics, licensed pharmacies and explicit safeguards.
04
Growth pathNetwork expansion
Broaden partner coverage and repeat workflows only after the initial model shows credible operating value.
05
OptionalityEnterprise rails
Explore selected institutional, payer and infrastructure opportunities once the core pathway is proven.
What earns the next stage
Four gates before scale.
Anthovian is sequencing product, partner, operating and governance proof so expansion follows evidence rather than ambition alone.
Product readiness
Test a focused end-to-end experience without widening the initial scope.
Partner alignment
Confirm that the model fits real clinic and pharmacy operating constraints.
Operating evidence
Measure whether the pathway improves clarity, coordination and follow-through.
Governance readiness
Establish the controls required for a responsible, partner-led pilot.
Start a conversation
Join the next proof point.
Anthovian is opening selective conversations with investors, clinics and licensed pharmacy partners aligned with a focused, responsible route to market.